Your browser doesn't support javascript.
loading
Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.
Xing, Hao; Zhang, Wan-Guang; Cescon, Matteo; Liang, Lei; Li, Chao; Wang, Ming-Da; Wu, Han; Lau, Wan Yee; Zhou, Ya-Hao; Gu, Wei-Min; Wang, Hong; Chen, Ting-Hao; Zeng, Yong-Yi; Schwartz, Myron; Pawlik, Timothy M; Serenari, Matteo; Shen, Feng; Wu, Meng-Chao; Yang, Tian.
Afiliação
  • Xing H; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Zhang WG; Department of Hepatic Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Cescon M; Department of Medical and Surgical Sciences, General Surgery and Transplantation Unit, University of Bologna, Italy.
  • Liang L; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Li C; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Wang MD; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Wu H; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Lau WY; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China; Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong Special Administrative Region.
  • Zhou YH; Department of Hepatobiliary Surgery, Pu'er People's Hospital, Yunnan, China.
  • Gu WM; The First Department of General Surgery, The Fourth Hospital of Harbin, Heilongjiang, China.
  • Wang H; Department of General Surgery, Liuyang People's Hospital, Hunan, China.
  • Chen TH; Department of General Surgery, Ziyang First People's Hospital, Sichuan, China.
  • Zeng YY; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital, Fujian Medical University, Fujian, China.
  • Schwartz M; Liver Cancer Program, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Pawlik TM; Department of Surgery, Ohio State University, Wexner Medical Center, Columbus, OH, United States.
  • Serenari M; Department of Medical and Surgical Sciences, General Surgery and Transplantation Unit, University of Bologna, Italy.
  • Shen F; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
  • Wu MC; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China. Electronic address: mengchao_wu@sina.com.
  • Yang T; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China. Electronic address: yangtianehbh@smmu.edu.cn.
HPB (Oxford) ; 22(5): 677-689, 2020 05.
Article em En | MEDLINE | ID: mdl-31607637
ABSTRACT

BACKGROUND:

A clear definition of "early recurrence" after hepatocellular carcinoma (HCC) resection is still lacking. This study aimed to determine the optimal cutoff between early and late HCC recurrence, and develop nomograms for pre- and postoperative prediction of early recurrence.

METHODS:

Patients undergoing HCC resection were identified from a multi-institutional Chinese database. Minimum P-value approach was adopted to calculate optimal cut-off to define early recurrence. Pre- and postoperative risk factors for early recurrence were identified and further used for nomogram construction. The results were externally validated by a Western cohort.

RESULTS:

Among 1501 patients identified, 539 (35.9%) were recurrence-free. The optimal length to distinguish between early (n = 340, 35.3%) and late recurrence (n = 622, 64.7%) was 8 months. Multivariable logistic regression analyses identified 5 preoperative and 8 postoperative factors for early recurrence, which were further incorporated into preoperative and postoperative nomograms (C-index 0.785 and 0.834). The calibration plots for the probability of early recurrence fitted well. The nomogram performance was maintained using the validation dataset (C-index 0.777 for preoperative prediction and 0.842 for postoperative prediction).

CONCLUSIONS:

An interval of 8 months was the optimal threshold for defining early HCC recurrence. The two web-based nomograms have been published to allow accurate pre- and postoperative prediction of early recurrence. These may offer useful guidance for individual treatment or follow up for patients with resectable HCC.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article